Back to Archived Journals » Virus Adaptation and Treatment » Volume 2 » default
Virus Adaptation and Treatment ceased publishing in May 2018. All articles that have been published in Virus Adaptation and Treatment will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Virus Adaptation and Treatment
ISSN: 1179-1624
- View all (53)
- Volume 10, 2018 (2)
- Volume 9, 2017 (4)
- Volume 8, 2016 (2)
- Volume 7, 2015 (5)
- Volume 6, 2014 (3)
- Volume 5, 2013 (2)
- Volume 4, 2012 (9)
- Volume 3, 2011 (8)
- Volume 2, 2010 (15)
- Volume 1, 2009 (3)
Archive: Volume 2, 2010
Viral vectors for cystic fibrosis gene therapy: What does the future hold?
Uta Griesenbach, Makoto Inoue, Mamoru Hasegawa, et al
Virus Adaptation and Treatment 2010, 2:159-171
Published Date: 13 December 2010
Antibody targeting of TSG101 on influenza-infected cells
Aurelio Bonavia, Leyla S Diaz, David Santos, et al
Virus Adaptation and Treatment 2010, 2:147-157
Published Date: 9 November 2010
An update on the management of glandular fever (infectious mononucleosis) and its sequelae caused by Epstein–Barr virus (HHV-4): new and emerging treatment strategies
A Martin Lerner, Safedin H Beqaj, Ken Gill, et al
Virus Adaptation and Treatment 2010, 2:135-145
Published Date: 23 September 2010
Small molecule inhibitors of the SARS-CoV Nsp15 endoribonuclease
J Ortiz-Alcantara, K Bhardwaj, S Palaninathan, et al.
Virus Adaptation and Treatment 2010, 2:125-133
Published Date: 6 September 2010
The role of herpesviruses in ocular infections
Asim V Farooq, Arpeet Shah, Deepak Shukla
Virus Adaptation and Treatment 2010, 2:115-123
Published Date: 1 September 2010
p38 and STAT3 activation by vGPCR in KSHV-infected cells
Mingli Liu, Shanchun Guo
Virus Adaptation and Treatment 2010, 2:103-113
Published Date: 6 September 2010
The next generation: etravirine in the treatment of HIV-1 infection in adults refractory to other antiretrovirals
R Chris Rathbun, Michelle D Liedtke
Virus Adaptation and Treatment 2010, 2:91-102
Published Date: 9 July 2010
An update on small molecule inhibitors of the HCV NS5B polymerase: effects on RNA synthesis in vitro and in cultured cells, and potential resistance in viral quasispecies
S Chinnaswamy, H Cai, C Kao
Virus Adaptation and Treatment 2010, 2:73-89
Published Date: 22 June 2010
Differential susceptibility of HIV strains to innate immune factors in human cervical-vaginal secretions
Mimi Ghosh, John V Fahey, Charles R Wira
Virus Adaptation and Treatment 2010, 2:63-71
Published Date: 1 July 2010
Resistance patterns and genetic variations in patients with hepatitis C virus: emerging role of telaprevir
C Argentini, D Genovese, S Catone
Virus Adaptation and Treatment 2010, 2:59-62
Published Date: 9 June 2010
Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome
A Martin Lerner, Safedin Beqaj, James T Fitzgerald, et al
Virus Adaptation and Treatment 2010, 2:47-57
Published Date: 24 May 2010
Poxviruses: smallpox vaccine, its complications and chemotherapy
Mimi Remichkova
Virus Adaptation and Treatment 2010, 2:41-46
Published Date: 20 April 2010
Conformations of the monomeric hepatitis C virus RNA-dependent RNA polymerase
Sreedhar Chinnaswamy, Ayaluru Murali, Hui Cai, et al
Virus Adaptation and Treatment 2010, 2:21-39
Published Date: 11 March 2010
Development of FGI-106 as a broad-spectrum therapeutic with activity against members of the family Bunyaviridae
Darci R Smith, Monica Ogg, Aura Garrison, et al
Virus Adaptation and Treatment 2010, 2:9-20
Published Date: 26 February 2010
A method for evaluating antiviral drug susceptibility of Epstein-Barr virus
Charlotte A Romain, Henry H Balfour Jr, Heather E Vezina, et al
Virus Adaptation and Treatment 2010, 2:1-7
Published Date: 25 January 2010